Answers are grounded in this paper and cite their sources.
Case report reveals self-limited torsade de pointes following droperidol treatment for nausea and vomiting, highlighting the need to screen for prolonged QT interval risk factors.
We report an emergency medical services (EMS) case of self-limited torsade de pointes after administration of droperidol for nausea and vomiting in a patient with potential predisposing factors for the development of prolonged QT interval. Despite the reported association with torsade de pointes, many clinicians still consider droperidol to be a safe medication. Rare cardiac side effects may be avoided by reviewing risk factors for prolonged QT interval in individual patients prior to administering droperidol.
No takes yet. Share an insight, caveat, or question.
Choo et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: